Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
1.820
0.00 (0.00%)
At close: Oct 8, 2025, 4:00 PM EDT
1.900
+0.080 (4.40%)
After-hours: Oct 8, 2025, 4:19 PM EDT
Repare Therapeutics Market Cap
Repare Therapeutics has a market cap or net worth of $78.19 million as of October 8, 2025. Its market cap has decreased by -47.67% in one year.
Market Cap
78.19M
Enterprise Value
-30.64M
1-Year Change
-47.67%
Ranking
Category
Stock Price
$1.82
Market Cap Chart
Since June 19, 2020, Repare Therapeutics's market cap has decreased from $945.76M to $78.19M, a decrease of -91.73%. That is a compound annual growth rate of -37.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 78.19M | 40.40% |
| Dec 31, 2024 | 55.69M | -81.89% |
| Dec 29, 2023 | 307.55M | -50.18% |
| Dec 30, 2022 | 617.25M | -29.87% |
| Dec 31, 2021 | 880.19M | -30.20% |
| Dec 31, 2020 | 1.26B | 33.34% |
| Jun 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 762.82B |
| Johnson & Johnson | 455.18B |
| AbbVie | 407.32B |
| UnitedHealth Group | 337.18B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.71B |